Clemex finalizes the strategic alliance with RAL Diagnostics
09 September 2011 - 5:56AM
PR Newswire (Canada)
MONTREAL, Sept. 8, 2011 /CNW/ -- The alliance based on a Share Swap
between the two Corporations licenses European market distribution
of the new Clemex system for Haematology applications Symbol:
CXG.A-TSX-V www.clemex.com Shares Outstanding: 23,999,810
MONTREAL, Sept. 8, 2011 /CNW Telbec/ - Clemex Technologies Inc.
(TSXV: CXG.A) announces it has received the TSX Exchange approval
and has finalized the strategic alliance with its European partner
RAL Diagnostics located in Martillac, France, to whom no previous
business links existed. This alliance will notably support the
marketing of its new instrument being developed for the Haematology
sector. According to the partnership signed between the two
Corporations, RAL will immediately become the exclusive distributor
of the new microscopy instruments developed by Clemex for
haematology and other life sciences applications in Europe. Clemex,
on the other hand, developed its new instrument for haematology to
primarily use the new MCDH stain solution created by RAL and will
also engage in working to develop new microscopy instruments in the
future using the various staining solutions created and
manufactured by RAL. A commercial partnership in Europe RAL
Diagnostic immediately becomes dealer of other image analysis
products manufactured by Clemex for all other microscopy
applications in France, Belgium and Switzerland. Finally, RAL will
become the privileged business partner of Clemex products for all
of Europe within a year, and will eventually become in charge of
all commercial activities such as distribution and marketing for
all of Europe. With such an important partner, Clemex, which was
only partially present in Europe, will strengthen its presence and
should increase its sales significantly to reach North America
sales levels in the near future. Business transaction With
completion of this transaction, Clemex holds 10% of RAL Diagnostics
share capital. RAL obtains in return 3 250 000 voting shares issued
by Clemex, representing 13.5% of all outstanding voting shares
issued by the Company. RAL Diagnostics, which already held 750 000
shares from a private placement concluded in 2008, will then hold,
16.7% of the outstanding voting shares of Clemex. Financial
Information RAL, which has a complementary microscopy line of
products to those of the image analysis microscopy products sold by
Clemex, has a Sales Volume, Net Equity and a Company size of about
30% higher than Clemex. (In Canadian dollars)
_____________________________________________________________________
| | Total | Total | Net | Sales |Sales in| Net | Nbr. | | |Assets |
Debts |Equity,|volume of| 2011 | Income | Of | | | March | March |
March |the last | (12 |in 2011,|Employees| | | 31, | 31 | 31 |4
fiscal |months) | (12 | | | | 2011 | RAL | 2011, |years (12|
|months) | | | | RAL |(April | RAL | months | | | | | |(April | 30
| (30 |periods) | | | | | | 30 | 2011, |avril, | | | | | | | 2011,
|Clemex)| 2011, | | | | | | |Clemex)| |Clemex)| | | | |
|_______|_______|_______|_______|_________|________|________|_________|
| | $ | $ | $ | $ | $ | $ | |
|_______|_______|_______|_______|_________|________|________|_________|
| | 4,7 M| 2,5 M| 2.2 M| | | | | |RAL(1 )| (2) | (3) | (4) | 25.8 M
| 6.6 M |510 276 | 40 |
|_______|_______|_______|_______|_________|________|________|_________|
|Clemex | 2,9 M | 1,6 M | 1,3 M | 19.7 M | 5.3 M |323 070 | 28 |
|_______|_______|_______|_______|_________|________|________|_________|
Note 1; French accounting reports (unaudited), French
standards, Accounting rules committee (ARC) Note 2; 3,5 M
Euros converted in Canadians dollars at a rate of 1.36 Note
3; 1.9 M Euros converted in Canadians dollars at a rate of
1.36 Note 4; 1,6 M Euros converted in Canadians dollars at a
rate of 1.36 About RAL Diagnostics RAL Diagnostics is a
manufacturer of biological stains intended for the field of human
and animal health, scientific research, medical diagnosis, and
industry. These stains are available in liquids or ready to use
kits. RAL Diagnostics serves 6,000 medical analysis laboratories
and anatomopathology laboratories of France thanks to a network of
35 distributors and 180 representatives. The company is present in
more than 40 countries in the world. About Clemex Technologies Inc.
Clemex Technologies Inc. develops, manufactures and markets image
analysis systems and software used by quality control and research
microscopy laboratories. Clemex customer base spans over many
countries in America, Europe, Asia and encompasses major Research
and Development Centers, prestigious Universities and large
manufacturing industries in various fields including healthcare,
automotive, aerospace, raw materials manufacturing,
pharmaceuticals, mining and other sectors. To view this news
release in HTML formatting, please use the following URL:
http://www.cnw.ca/en/releases/archive/September2011/08/c9642.html p
bClemex Technologies Inc,/bbr/ 800 Guimond,br/ Longueuil, QC,
Canada J4G 1T5, /p p Contact: /p p align="justify" Clément
Forgetbr/ Tel: 450.651.6573br/ Email: a
href="mailto:ir@clemex.com"ir@clemex.com/a /p
Copyright
Clemex Technologies Inc. (TSXV:CXG.A)
Historical Stock Chart
From Jun 2024 to Jul 2024
Clemex Technologies Inc. (TSXV:CXG.A)
Historical Stock Chart
From Jul 2023 to Jul 2024